The DOI matches its Crossref record; 41 of the 42 references it cites were found in a registry or an index.
Time Course of Transgene Expression After Intrastriatal Pseudotyped rAAV2/1, rAAV2/2, rAAV2/5, and rAAV2/8 Transduction in the Rat
Open accessAbstract
In vivo recombinant adeno-associated viral vector (rAAV)-mediated transduction of various tissues including brain has been characterized by slow onset and gradual increase in gene expression before reaching stable long-term protein levels. The early time course of transgene expression has not been quantified using newly available rAAV capsid serotypes. In this experiment, the onset of expression of green fluorescent protein (GFP) after intrastriatal injection of rAAV2-based pseudotyped vectors (rAAV1, rAAV5, and rAAV8 capsids) was quantified. Native GFP fluorescence displayed a delayed onset of expression of at least 7 days for all the pseudotyped rAAV vectors. However, GFP immunohistochemical staining revealed significant transgene expression by 4 days after transduction for all serotypes and stable GFP(+) neuronal populations mediated by all serotypes within 14 days post transduction at the latest. rAAV2/1 and rAAV2/2 displayed no time-dependent increase of GFP(+) striatal neurons; reaching maximal striatal cell GFP(+) counts at 4 days after injection. All serotypes displayed peak transgene expression by 4 weeks post injection where native GFP(+) neurons were equal to immunostained striatal GFP(+) neurons. The inflammatory response to these rAAV vectors was present up to 4 weeks after transduction but was not apparent 9 months post injection. Thus, rAAV-mediated transgene expression begins earlier than previously thought.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In our previous work, we have seen that a capsid and/or transgene related inflammatory response peaks at 2-weeks post-injection and then retracts to the needle track [46], similarly to what is seen with the Olig001-GFP injected monkeys.”
From Novel oligodendroglial alpha synuclein viral vector models of multiple system atrophy: studies in rodents and nonhuman primates (2017) · cites this paper as [46]
Citations
Cites
Efficient selection for high-expression transfectants with a novel eukaryotic vector
Niwa, H., Yamamura, K., & Miyazaki, J. (1991) · Gene · doi:10.1016/0378-1119(91)90434-d · Cited by 5,149
West, M. J., Slomianka, L., & Gundersen, H. J. G. (1991) · The Anatomical Record · doi:10.1002/ar.1092310411 · Cited by 2,994
Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy
Gao, G.-P., Alvira, M. R., Wang, L., Calcedo, R., Johnston, J., & Wilson, J. M. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.182412299 · Cited by 1,520
The efficiency of systematic sampling in stereology—reconsidered
GUNDERSEN, H. J. G., JENSEN, E. B. V., KIÊU, K., & NIELSEN, J. (1999) · Journal of Microscopy · doi:10.1046/j.1365-2818.1999.00457.x · Cited by 1,317
Ferrari, F. K., Samulski, T., Shenk, T., & Samulski, R. J. (1996) · Journal of Virology · doi:10.1128/jvi.70.5.3227-3234.1996 · Cited by 761
Burger, C., Gorbatyuk, O. S., Velardo, M. J., Peden, C. S., Williams, P., Zolotukhin, S., Reier, P. J., Mandel, R. J., & Muzyczka, N. (2004) · Molecular Therapy · doi:10.1016/j.ymthe.2004.05.024 · Cited by 741
Self-citationKessler, P., Podsakoff, G. M., Chen, X., McQuiston, S. A., Colosi, P., Matelis, L. A., Kurtzman, G. J., & Byrne, B. J. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.24.14082 · Cited by 614
A "humanized" green fluorescent protein cDNA adapted for high-level expression in mammalian cells
Zolotukhin, S., Potter, M., Hauswirth, W. W., Guy, J., & Muzyczka, N. (1996) · Journal of Virology · doi:10.1128/jvi.70.7.4646-4654.1996 · Cited by 609
Self-citationProduction and purification of serotype 1, 2, and 5 recombinant adeno-associated viral vectors
Zolotukhin, S., Potter, M., Zolotukhin, I., Sakai, Y., Loiler, S., Fraites, T. J., Chiodo, V. A., Philipsberg, T., Muzyczka, N., Hauswirth, W. W., et al. (2002) · Methods · doi:10.1016/s1046-2023(02)00220-7 · Cited by 564
Self-citationHerzog, R. W., Yang, E. Y., Couto, L. B., Hagstrom, J. N., Elwell, D., Fields, P. A., Burton, M., Bellinger, D. A., Read, M. S., Brinkhous, K. M., et al. (1999) · Nature Medicine · doi:10.1038/4743 · Cited by 554
Cited by
Sorted by citations
Comparative Analysis of Adeno-Associated Viral Vector Serotypes 1, 2, 5, 7, And 8 in Mouse Brain
Taymans, J.-M., Vandenberghe, L. H., Haute, C. V. D., Thiry, I., Deroose, C. M., Mortelmans, L., Wilson, J. M., Debyser, Z., & Baekelandt, V. (2007) · Human Gene Therapy · doi:10.1089/hum.2006.178 · Cited by 305
Adeno-Associated Virus Technologies and Methods for Targeted Neuronal Manipulation
Haery, L., Deverman, B. E., Matho, K. S., Cetin, A. H., Woodard, K., Cepko, C. L., Guerin, K. I., Rego, M. A., Ersing, I., Bächle, S. M., et al. (2019) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2019.00093 · Cited by 220
Klein, R. L., Dayton, R. D., Tatom, J. B., Henderson, K. M., & Henning, P. P. (2008) · Molecular Therapy · doi:10.1038/sj.mt.6300331 · Cited by 196
Rapid axonal sprouting and pruning accompany functional reorganization in primary visual cortex
Yamahachi, H., Marik, S. A., McManus, J. N. J., Denk, W., & Gilbert, C. D. (2009) · Neuron · doi:10.1016/j.neuron.2009.11.026 · Cited by 193
Oliveras-Salvá, M., Van der Perren, A., Casadei, N., Stroobants, S., Nuber, S., D’Hooge, R., Van den Haute, C., & Baekelandt, V. (2013) · Molecular Neurodegeneration · doi:10.1186/1750-1326-8-44 · Cited by 191
Fenno, L. E., Ramakrishnan, C., Kim, Y. S., Evans, K. E., Lo, M., Vesuna, S. S., Inoue, M., Cheung, K. Y. M., Yuen, E., Pichamoorthy, N., et al. (2020) · Neuron · doi:10.1016/j.neuron.2020.06.003 · Cited by 180
Lawlor, P. A., Bland, R. J., Mouravlev, A., Young, D., & During, M. J. (2009) · Molecular Therapy · doi:10.1038/mt.2009.170 · Cited by 161
Lowenstein, P. R., Mandel, R. J., Xiong, W.-D., Kroeger, K. M., & Castro, M. G. (2007) · Current Gene Therapy · doi:10.2174/156652307782151498 · Cited by 157
Self-citationCastle, M. J., Gershenson, Z. T., Giles, A. R., Holzbaur, E. L. F., & Wolfe, J. H. N. (2014) · Human Gene Therapy · doi:10.1089/hum.2013.189 · Cited by 165
Controlling AAV Tropism in the Nervous System with Natural and Engineered Capsids
Castle, M. J., Turunen, H. T., Vandenberghe, L. H., & Wolfe, J. H. (2016) · Methods in Molecular Biology · doi:10.1007/978-1-4939-3271-9_10 · Cited by 151
“AAV2 diffuses less readily through both the brain and spinal cord parenchyma when compared against other serotypes, and therefore mediates transduction over a smaller area [19, 28, 32, 33].”
BackgroundMcFarland, N. R., Fan, Z., Xu, K., Schwarzschild, M. A., Feany, M. Β., Hyman, B. T., & McLean, P. J. (2009) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181a24b53 · Cited by 131
Viral vector-mediated overexpression of α-synuclein as a progressive model of Parkinson’s disease
Ulusoy, A., Decressac, M., Kirik, D., & Björklund, A. (2010) · Progress in brain research · doi:10.1016/s0079-6123(10)84005-1 · Cited by 141
A comprehensive multiscale framework for simulating optogenetics in the heart
Boyle, P. M., Williams, J. C., Ambrosi, C. M., Entcheva, E. G., & Trayanova, N. A. (2013) · Nature Communications · doi:10.1038/ncomms3370 · Cited by 125
Towne, C., Schneider, B. L., Kieran, D., Redmond, D. E., & Aebischer, P. (2010) · Gene Therapy · doi:10.1038/gt.2009.119 · Cited by 124
Manfredsson, F. P., Tümer, N., Erdös, B., Landa, T., Broxson, C. S., Sullivan, L. F., Rising, A. C., Foust, K. D., Zhang, Y., Muzyczka, N., et al. (2009) · Molecular Therapy · doi:10.1038/mt.2009.45 · Cited by 100
Self-citationCastle, M. J., Perlson, E., Holzbaur, E. L. F., & Wolfe, J. H. N. (2013) · Molecular Therapy · doi:10.1038/mt.2013.237 · Cited by 98
Striatal Overexpression of ΔFosB Reproduces Chronic Levodopa-Induced Involuntary Movements
Cao, X., Yasuda, T., Uthayathas, S., Watts, R. L., Mouradian, M. M., Mochizuki, H., & Papa, S. M. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.0252-10.2010 · Cited by 96
McFarland, N. R., Lee, J., Hyman, B. T., & McLean, P. J. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06010.x · Cited by 91
der Perren, A. V., Toelen, J., Carlon, M. S., den Haute, C. V., Coun, F., Heeman, B., Reumers, V., Vandenberghe, L. H., Wilson, J. M., Debyser, Z., et al. (2011) · Gene Therapy · doi:10.1038/gt.2010.179 · Cited by 88
Evading the immune response upon in vivo gene therapy with viral vectors.
Sack, B. K., & Herzog, R. W. (2009) · PubMed · Cited by 92
Dodiya, H. B., Bjorklund, T., Stansell III, J., Mandel, R. J., Kirik, D., & Kordower, J. H. (2010) · Molecular Therapy · doi:10.1038/mt.2009.216 · Cited by 86
Self-citationElMallah, M. K., Falk, D. J., Nayak, S., Federico, R. A., Sandhu, M. S., Poirier, A. E., Byrne, B. J., & Fuller, D. D. (2013) · Molecular Therapy · doi:10.1038/mt.2013.282 · Cited by 82
Gene Therapy in Parkinsonʼs Disease
Feng, L., & Maguire‐Zeiss, K. A. (2010) · CNS Drugs · doi:10.2165/11533740-000000000-00000 · Cited by 80
Snyder‐Keller, A., McLear, J. A., Hathorn, T., & Messer, A. C. (2010) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181f530ec · Cited by 76
Rationally Engineered AAV Capsids Improve Transduction and Volumetric Spread in the CNS
Kanaan, N. M., Sellnow, R. C., Boye, S. L., Coberly, B., Bennett, A. D., Agbandje‐McKenna, M., Sortwell, C. E., Hauswirth, W. W., Boye, S. L., & Manfredsson, F. P. (2017) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2017.06.011 · Cited by 77
Self-citationVelde, G. V., Rangarajan, J. R., Toelen, J., Dresselaers, T., Ibrahimi, A., Krylychkina, O., Vreys, R., der Linden, A. V., Maes, F., Debyser, Z., et al. (2011) · Gene Therapy · doi:10.1038/gt.2011.2 · Cited by 76
Cunningham, J., Pivirotto, P., Bringas, J., Suzuki, B. M., Vijay, S., Sanftner, L. M., Kitamura, M., Chan, C. M., & Bankiewicz, K. S. (2008) · Molecular Therapy · doi:10.1038/mt.2008.111 · Cited by 70
Tight Long-term Dynamic Doxycycline Responsive Nigrostriatal GDNF Using a Single rAAV Vector
Manfredsson, F. P., Bürger, C., Rising, A. C., Zuobi-Hasona, K., Sullivan, L. F., Lewin, A. S., Huang, J. H., Piercefield, E. W., Muzyczka, N., & Mandel, R. J. (2009) · Molecular Therapy · doi:10.1038/mt.2009.196 · Cited by 67
Self-citationNew tools for investigating astrocyte-to-neuron communication
Li, D., Agulhon, C., Schmidt, E. M., Oheim, M., & Ropert, N. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00193 · Cited by 76
Sellnow, R. C., Newman, J. H., Chambers, N., West, A. R., Steece‐Collier, K., Sandoval, I. M., Benskey, M. J., Bishop, C., & Manfredsson, F. P. (2019) · Acta Neuropathologica Communications · doi:10.1186/s40478-018-0653-7 · Cited by 64
Self-citationScheyltjens, I., Laramée, M., den Haute, C. V., Gijsbers, R., Debyser, Z., Baekelandt, V., Vreysen, S., & Arckens, L. (2015) · The Journal of Comparative Neurology · doi:10.1002/cne.23819 · Cited by 57
Mandel, R. J., Marmion, D. J., Kirik, D., Chu, Y., Heindel, C., McCown, T., Gray, S. J., & Kordower, J. H. (2017) · Acta Neuropathologica Communications · doi:10.1186/s40478-017-0451-7 · Cited by 55
Self-citationGorbatyuk, O. S., Li, S., Nguyen, F. N., Manfredsson, F. P., Kondrikova, G., Sullivan, L. F., Meyers, C., Chen, W., Mandel, R. J., & Muzyczka, N. (2010) · Molecular Therapy · doi:10.1038/mt.2010.137 · Cited by 56
Self-citationBenskey, M. J., Sandoval, I. M., & Manfredsson, F. P. (2016) · Human Gene Therapy Methods · doi:10.1089/hgtb.2015.117 · Cited by 52
Self-citationBjörklund, T., Carlsson, T., Cederfjäll, E. A., Carta, M., & Kirik, D. (2010) · Brain · doi:10.1093/brain/awp314 · Cited by 48
Benskey, M. J., Kuhn, N. C., Galligan, J. J., Garcia, J., Boye, S. L., Hauswirth, W. W., Mueller, C., Boye, S. L., & Manfredsson, F. P. (2015) · Molecular Therapy · doi:10.1038/mt.2015.7 · Cited by 48
Self-citationManfredsson, F. P., Okun, M. S., & Mandel, R. J. (2009) · Current Gene Therapy · doi:10.2174/156652309789753400 · Cited by 46
Self-citationPeden, C. S., Manfredsson, F. P., Reimsnider, S. K., Poirier, A. E., Burger, C., Muzyczka, N., & Mandel, R. J. (2009) · Molecular Therapy · doi:10.1038/mt.2008.284 · Cited by 44
“This experiment revealed that there is no loss of striatal rAAV2/2 vector genomes in the second injected site of readministered animals [Figure 9d, F(3,24) = 3.”
BackgroundSelf-citationFulton, S. L., Mitra, S., Lepack, A. E., Martin, J. A., Stewart, A. F., Converse, J., Hochstetler, M. J., Dietz, D., & Maze, I. S. (2022) · Neuropsychopharmacology · doi:10.1038/s41386-022-01279-4 · Cited by 45
High Transgene Expression by Lentiviral Vectors Causes Maldevelopment of Purkinje Cells In Vivo
Sawada, Y., Kajiwara, G., Iizuka, A., Takayama, K., Shuvaev, А. N., Koyama, C., & Hirai, H. (2010) · The Cerebellum · doi:10.1007/s12311-010-0161-1 · Cited by 42
Mandel, R. J., Bürger, C., & Snyder, R. O. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2007.08.008 · Cited by 44
Self-citationChiu, T., Wang, M.-J., & Su, C. (2012) · Journal of Biomedical Science · doi:10.1186/1423-0127-19-45 · Cited by 42
Pronounced microgliosis and neurodegeneration in aged rats after tau gene transfer
Klein, R. L., Dayton, R. D., Diaczynsky, C. G., & Wang, D. B. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.12.002 · Cited by 39
A role for BDNF in cocaine reward and relapse
Schoenbaum, G. M., Stalnaker, T. A., & Shaham, Y. (2007) · Nature Neuroscience · doi:10.1038/nn0807-935 · Cited by 39
Qi, X., Guzhva, L., Yang, Z., Febo, M., Shan, Z. J., Wang, K., & Bruijnzeel, A. W. (2016) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2016.07.007 · Cited by 39
Kou, J., Kim, H.-D., Pattanayak, A., Song, M., Lim, J.-E., Taguchi, H., Paul, S., Cirrito, J. R., Ponnazhagan, S., & Fukuchi, K.-I. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-110230 · Cited by 37
Cederfjäll, E. A., Şahin, G., Kirik, D., & Björklund, T. (2012) · Molecular Therapy · doi:10.1038/mt.2012.1 · Cited by 37
Bile diversion, a bariatric surgery, and bile acid signaling reduce central cocaine reward
Reddy, I. A., Smith, N. K., Erreger, K., Ghose, D., Saunders, C., Foster, D. J., Turner, B. D., Poe, A. M., Albaugh, V. L., McGuinness, O. P., et al. (2018) · PLoS Biology · doi:10.1371/journal.pbio.2006682 · Cited by 37
AAV1 is the optimal viral vector for optogenetic experiments in pigeons (Columba livia)
Rook, N., Tuff, J. M., Isparta, S., Masseck, O. A., Herlitze, S., Güntürkün, O., & Pusch, R. (2021) · Communications Biology · doi:10.1038/s42003-020-01595-9 · Cited by 40
Fischer, D. L., Manfredsson, F. P., Kemp, C. J., Cole-Strauss, A., Lipton, J. W., Duffy, M. F., Polinski, N. K., Steece‐Collier, K., Collier, T. J., Gombash, S. E., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-16690-x · Cited by 33
Self-citationGHS-R1a signaling in the DMH and VMH contributes to food anticipatory activity
Merkestein, M., van Gestel, M. A., van der Zwaal, E. M., Brans, M. A. D., Luijendijk, M. C. M., van Rozen, A. J., Hendriks, J., Garner, K. M., Boender, A. J., Pandit, R., et al. (2013) · International Journal of Obesity · doi:10.1038/ijo.2013.131 · Cited by 35
Gombash, S. E., Lipton, J. W., Collier, T. J., Madhavan, L., Steece‐Collier, K., Cole-Strauss, A., Terpstra, B. T., Spieles-Engemann, A. L., Daley, B. F., Wohlgenant, S. L., et al. (2011) · Molecular Therapy · doi:10.1038/mt.2011.216 · Cited by 33
Self-citationWu, K., Li, S., Bodhinathan, K., Meyers, C., Chen, W., Campbell‐Thompson, M., McIntyre, L. M., Foster, T. C., Muzyczka, N., & Kumar, A. (2011) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2011.09.006 · Cited by 32
Self-citationMelanocortin receptor-mediated effects on obesity are distributed over specific hypothalamic regions
de Backer, M. W. A., la Fleur, S. E., Brans, M. A. D., van Rozen, A. J., Luijendijk, M. C. M., Merkestein, M., Garner, K. M., van der Zwaal, E. M., & Adan, R. A. H. (2010) · International Journal of Obesity · doi:10.1038/ijo.2010.169 · Cited by 33
Kneynsberg, A., Collier, T. J., Manfredsson, F. P., & Kanaan, N. M. (2016) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2016.03.004 · Cited by 31
Self-citationOptimization of Adeno-Associated Viral Vector-Mediated Gene Delivery to the Hypothalamus
de Backer, M. W. A., Brans, M. A. D., Luijendijk, M. C. M., Garner, K. M., & Adan, R. A. H. (2010) · Human Gene Therapy · doi:10.1089/hum.2009.169 · Cited by 29
Intraparenchymal Stereotaxic Delivery of rAAV and Special Considerations in Vector Handling
Benskey, M. J., & Manfredsson, F. P. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-3271-9_14 · Cited by 28
Self-citationIn vivo methods for acute modulation of gene expression in the central nervous system
Cwetsch, A. W., Pinto, B., Savardi, A., & Cancedda, L. (2018) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2018.04.008 · Cited by 26
Cellular glycan modification by B3GAT1 broadly restricts influenza virus infection
Trimarco, J. D., Nelson, S. L., Chaparian, R. R., Wells, A. I., Murray, N. B., Azadi, P., Coyne, C. B., & Heaton, N. S. (2022) · Nature Communications · doi:10.1038/s41467-022-34111-0 · Cited by 25
Jiang, R., Haustein, M. D., Sofroniew, M. V., & Khakh, B. S. (2014) · Journal of Visualized Experiments · doi:10.3791/51972 · Cited by 26
Impact of age and vector construct on striatal and nigral transgene expression
Polinski, N. K., Manfredsson, F. P., Benskey, M. J., Fischer, D. L., Kemp, C. J., Steece‐Collier, K., Sandoval, I. M., Paumier, K. L., & Sortwell, C. E. (2016) · Molecular Therapy — Methods & Clinical Development · doi:10.1038/mtm.2016.82 · Cited by 25
Self-citationQi, X., Shan, Z. J., Ji, Y., Guerra, V., Alexander, J. C., Ormerod, B. K., & Bruijnzeel, A. W. (2014) · Translational Psychiatry · doi:10.1038/tp.2014.25 · Cited by 24
β1-Integrins in the Developing Orbitofrontal Cortex Are Necessary for Expectancy Updating in Mice
DePoy, L. M., Shapiro, L. P., Kietzman, H. W., Roman, K. M., & Gourley, S. L. (2019) · Journal of Neuroscience · doi:10.1523/jneurosci.3072-18.2019 · Cited by 20
Ojano-Dirain, C. P., Glushakova, L. G., Li, Z., Zolotukhin, S., Muzyczka, N., Srivastava, A., & Stacpoole, P. W. (2010) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2010.07.008 · Cited by 19
Self-citationGene Therapy for Misfolding Protein Diseases of the Central Nervous System
Sebastián, W. S., Samaranch, L., Kells, A. P., Forsayeth, J., & Bankiewicz, K. S. (2013) · Neurotherapeutics · doi:10.1007/s13311-013-0191-8 · Cited by 17
Gene transfer of integration defective anti-HSV-1 meganuclease to human corneas ex vivo
Elbadawy, H. M., Gailledrat, M., Desseaux, C., Salvalaio, G., Iorio, E. D., Ferrari, B., Bertolin, M., Barbaro, V., Parekh, M., Gayon, R., et al. (2014) · Gene Therapy · doi:10.1038/gt.2013.82 · Cited by 18
Hernandez, J. S., Binette, A. N., Rahman, T., Tarantino, J. D., & Moorman, D. E. (2020) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.14407 · Cited by 21
Doherty, F. C., Schaack, J. B., & Sladek, C. D. (2011) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2011.02.026 · Cited by 18
Recombinant Adeno-Associated Virus: Efficient Transduction of the Rat VMH and Clearance from Blood
van Gestel, M. A., Boender, A. J., de Vrind, V. A. J., Garner, K. M., Luijendijk, M. C. M., & Adan, R. A. H. (2014) · PLoS ONE · doi:10.1371/journal.pone.0097639 · Cited by 18
Sanchez, C. E., Tierney, T. S., Gale, J. T., Alavian, K. N., Sahin, A., Lee, J.-S., Mulligan, R. C., & Carter, B. S. (2010) · Journal of neurosurgery · doi:10.3171/2010.8.jns091583 · Cited by 15
Yegla, B., & Parikh, V. (2017) · Behavioural Brain Research · doi:10.1016/j.bbr.2017.08.017 · Cited by 15
Bockstael, O., Melas, C., Pythoud, C., Levivier, M., McCarty, D. M., Samulski, R. J., Witte, O. D., & Tenenbaum, L. (2012) · Human Gene Therapy · doi:10.1089/hum.2011.216 · Cited by 15
Owusu-Yaw, B. S., Zhang, Y., Garrett, L., Yao, A., Shing, K., Batista, A. R., Sena‐Esteves, M., Upadhyay, J., Kegel-Gleason, K. B., & Todd, N. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16060710 · Cited by 17
Minnig, M. A., Park, T., Sanchez, M. E., Cottone, P., & Sabino, V. (2021) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2021.787362 · Cited by 11
de Backer, M. W. A., Fitzsimons, C. P., Brans, M. A. D., Luijendijk, M. C. M., Garner, K. M., Vreugdenhil, E., & Adan, R. A. H. (2010) · BMC Neuroscience · doi:10.1186/1471-2202-11-81 · Cited by 15
Dhanushkodi, A., Xue, Y., Roguski, E. E., Ding, Y., Matta, S. G., Heck, D. H., Fan, G.-H., & McDonald, M. P. (2018) · Neuroscience Letters · doi:10.1016/j.neulet.2018.10.038 · Cited by 13
A brief guide for gene delivery to the brain using adeno-associated viral vectors
Han, S., Yang, E. M., & Hur, E. (2025) · Molecules and Cells · doi:10.1016/j.mocell.2025.100189 · Cited by 13
The Degenerating Substantia Nigra as a Susceptible Region for Gene Transfer-Mediated Inflammation
Roca, V., Casabona, J. C., Radice, P. D., Murta, V., & Pitossi, F. J. (2011) · Parkinson s Disease · doi:10.4061/2011/931572 · Cited by 12
Chtarto, A., Bockstael, O., Gebara, E., Vermoesen, K., Melas, C., Pythoud, C., Levivier, M., Witte, O. D., Luthi‐Carter, R., Clinkers, R., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0053156 · Cited by 13
Yang, C., Hao, F., He, J., Lu, T., Klein, R. L., Zhao, L., & Duan, W. (2016) · Human Gene Therapy · doi:10.1089/hum.2015.083 · Cited by 12
Yang, C., Yang, W., Chen, S., Bao-feng, M., Li, B., Lu, T., Qu, T., Klein, R. L., Zhao, L., & Duan, W. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063876 · Cited by 9
Peripapillary Intravitreal Injection Improves AAV-Mediated Retinal Transduction
Madrakhimov, S. B., Yang, J. Y., Ahn, D. H., Han, J. W., Ha, T. H., & Park, T. K. (2020) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2020.03.018 · Cited by 10
Recombinant Adeno-Associated Viral Vectors
de Backer, M. W. A., Garner, K. M., Luijendijk, M. C. M., & Adan, R. A. H. (2011) · Methods in molecular biology · doi:10.1007/978-1-61779-310-3_24 · Cited by 9
Gross, D., Ghenassia, A., Bartolo, L., Urbain, D., Benkhelifa‐Ziyyat, S., Lorain, S., Davoust, J. M., & Chappert, P. (2018) · Journal of Virology · doi:10.1128/jvi.01334-18 · Cited by 10
Luchicchi, A., Pattij, T., Viaña, J. N. M., de Kloet, S. F., & Marchant, N. J. (2020) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2020.109004 · Cited by 8
Stevens, L., Larsen, L. E., Lysebettens, W. V., Carrette, E., Boon, P., Raedt, R., & Vonck, K. E. J. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.663337 · Cited by 8
Prospect of Induced Pluripotent Stem Cell Genetic Repair to Cure Genetic Diseases
Pawitan, J. A. (2012) · Stem Cells International · doi:10.1155/2012/498197 · Cited by 8
Zhang, Y., Gao, Y., Speth, R. C., Jiang, N., Mao, Y., Sumners, C., & Li, H. (2013) · International Journal of Medical Sciences · doi:10.7150/ijms.5700 · Cited by 7
Yang, P., Qin, Y., Zhang, W., Bian, Z., & Wang, R. L. (2015) · Journal of Molecular Neuroscience · doi:10.1007/s12031-015-0610-x · Cited by 7
Adeno-associated virus-mediated ILK gene silencing in the rat NAc core
Chen, Q., Xiong, X., Lee, T. H., Liu, Y., Sun, Q.-A., Wetsel, W. C., & Zhang, X. (2008) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2008.06.004 · Cited by 7
Daw, T. B., El-Nahal, H. G., Basso, M. A., Jun, E. J., Bautista, A. R., Samulski, R. J., Sommer, M. A., & Bohlen, M. O. (2023) · Human Gene Therapy · doi:10.1089/hum.2022.194 · Cited by 6
Thiele, N., Hildebrandt, K. J., & Köppl, C. (2020) · Current Research in Neurobiology · doi:10.1016/j.crneur.2020.100001 · Cited by 6
Masri, S., Mowery, T. M., Fair, R., & Sanes, D. H. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2311570121 · Cited by 8
Optogenetic stimulation of a cortical biohybrid implant guides goal directed behaviorPreprint
Brown, J., Zappitelli, K. M., Dawson, P. M., Yoon, E., Shiraga, S., Rochford, A. E., Eltaeb, M., Rodriguez, A., Kong, Y., Hodak, M., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.11.22.624907 · Cited by 7
von Hövel, F. F., Rumpel, R., Ratzka, A., Schreiner, D., & Grothe, C. (2019) · Cell and Tissue Research · doi:10.1007/s00441-019-03013-x · Cited by 6
Zhu, Q.-X., Zhang, Y., Zhang, H., Leng, C., Deng, C.-L., Wang, X., Li, J.-J., Ye, X.-L., Zhang, B., & Li, X. (2024) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0012604 · Cited by 5
Chronic Two-Photon Imaging of Neural Activity in the Anesthetized and Awake Behaving Rodent
Margolis, D. J., Lütcke, H., Helmchen, F., Weber, B., & Haiss, F. (2013) · Neuromethods · doi:10.1007/978-1-62703-785-3_10 · Cited by 6
Microarray profiling of hypothalamic gene expression changes in Huntington’s disease mouse models
Dickson, E., Dwijesha, A. S., Andersson, N., Lundh, S. H., Björkqvist, M., Petersén, Å., & Soylu-Kucharz, R. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.1027269 · Cited by 6
McManus, G., Centner, A., Budrow, C., Lipari, N., Tseng, K. Y., Manfredsson, F. P., & Bishop, C. (2024) · Neuropharmacology · doi:10.1016/j.neuropharm.2024.110227 · Cited by 4
Self-citationUsing Recombinant Adeno-Associated Viral Vectors for Gene Expression in the Brain
der Perren, A. V., Toelen, J., Taymans, J., & Baekelandt, V. (2011) · Neuromethods · doi:10.1007/978-1-61779-533-6_3 · Cited by 4
Metadata
- Authors
- Reimsnider, S., Manfredsson, F. P., Muzyczka, N., & Mandel, R. J.
- Affiliations
- University of Florida Health (US)
- Corresponding author
- Mandel, Ronald J
- Venue
- Molecular Therapy
- Publisher
- Elsevier BV
- Published
- 2007-08
- Volume
- 15
- Issue
- 8
- Pages
- 1504-1511
- ISSN
- 1525-0016 (ISSN-L)
- OpenAlex
- W1983678138
- Cited by
- 125
- References
- 42
- Citations by year
- 2026: 7 · 2025: 6 · 2024: 6 · 2023: 6 · 2022: 3 · 2021: 4 · 2020: 7 · 2019: 4 · 2018: 5 · 2017: 4 · 2016: 6 · 2015: 5 · 2014: 5 · 2013: 11 · 2012: 4
- FWCI
- 5.53
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Molecular Therapy (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- University of Florida
- National Institute of Neurological Disorders and Stroke (P01NS036302, P01NS36302)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Keywords
- recombinant adeno-associated virus vectors, intrastriatal injection, striatal neurons, green fluorescent protein, neuroinflammation, gene therapy
- MeSH terms
- Adenoviridae, Animals, Cell Differentiation, DNA, Recombinant, Female, Genetic Vectors, Neuroglia, Time Factors, Transduction, Genetic, Gene Expression, Rats, Sprague-Dawley, Genes, Reporter, Transgenes, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review